Cancer Family
Esophageal Neoplasm
CI-CAN-00000174Explore in graph →
Non-malignant555 active trials6 approved drugs12 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000174Explore in graph →
Clinical trials
2,208 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02721576 | A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCC | terminated | Phase 4 | 8 | Shandong Cancer Hospital and InstituteOTHER | 1 | Oct 11, 2019 | clinicaltrials |
| NCT03211780 | Use of Intra-Operative Shear Wave Ultrasound Vibrometry for Characterization of Esophageal Malignant Tumors | terminated | N/A | 3 | Mayo ClinicOTHER | 1 | Oct 4, 2019 | clinicaltrials |
| NCT02062632 |
| Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy |
| terminated |
| Phase 2 |
| 5 |
| Mayo ClinicOTHER |
| 1 |
| Oct 1, 2019 |
| clinicaltrials |
| NCT02457299 | Esophagectomy With or Without Prior Ischemic Gastric Preconditioning | terminated | N/A | 1 | Endeavor HealthOTHER | 1 | Aug 5, 2019 | clinicaltrials |
| NCT01248299 | Benefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer.(E-DIS) | terminated | Phase 2 | 105 | Centre Oscar LambretOTHER | 1 | May 16, 2019 | clinicaltrials |
| NCT00653107 | Palliation Dysphagia Cancer Oesophagus Stent+Brachytherapy Versus Brachytherapy Only(PACO) | terminated | Phase 3 | 41 | Oslo University HospitalOTHER | 1 | May 14, 2019 | clinicaltrials |
| NCT03122548 | Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers | terminated | Phase 2 | 5 | Aduro Biotech, Inc.INDUSTRY | 1 | Apr 4, 2019 | clinicaltrials |
| NCT02547142 | Early Integration of Palliative Care in Esophageal Cancer Patients | terminated | N/A | 12 | McMaster UniversityOTHER | 1 | Mar 14, 2019 | clinicaltrials |
| NCT02584400 | Tumor Hypoxia With HX4 PET in Several Diseases(HX4 SD) | terminated | Phase 2 | 1 | Maastricht Radiation OncologyOTHER | 1 | Mar 8, 2019 | clinicaltrials |
| NCT01372202 | CHFR Methylation Status Esophageal Cancer Study(J10130) | terminated | Phase 2 | 31 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT02221245 | Wnt, Notch and Hedgehog Activity in Chemo-Naive Tumors Collected During Staging of Esophageal Cancer Patients | terminated | — | 24 | University of MiamiOTHER | 1 | Jan 15, 2019 | clinicaltrials |
| NCT00493025 | Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery | terminated | Phase 2 | 19 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Dec 6, 2018 | clinicaltrials |
| NCT01446874 | Prevention of Post-operative Pneumonia (POPP)(POPP) | terminated | Phase 2 / Phase 3 | 150 | Washington University School of MedicineOTHER | 1 | Nov 8, 2018 | clinicaltrials |
| NCT03223662 | Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy | terminated | Phase 2 | 2 | National Cancer Institute (NCI)NIH | 1 | Oct 30, 2018 | clinicaltrials |
| NCT02234180 | Regorafenib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Who Have Completed Chemoradiation Therapy and Surgery | terminated | Phase 2 | 3 | Academic and Community Cancer Research UnitedOTHER | 1 | Oct 17, 2018 | clinicaltrials |
| NCT01471249 | Quality of Life and Dysphagia Following Palliative Stenting in Esophageal Cancer | terminated | — | 13 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Sep 17, 2018 | clinicaltrials |
| NCT02358863 | Molecularly Tailored Therapy for Patients With Metastatic Cancer of the Esophagus and Stomach(mEGA) | terminated | N/A | 13 | Georgetown UniversityOTHER | 1 | Sep 6, 2018 | clinicaltrials |
| NCT01608464 | Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer | terminated | Phase 2 | 170 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Aug 10, 2018 | clinicaltrials |
| NCT01795976 | NY-ESO-1 T Cells in OG Cancer(ATTACK-OG) | terminated | Phase 2 | 2 | Fiona ThistlethwaiteOTHER | 1 | Aug 7, 2018 | clinicaltrials |
| NCT03540953 | Endoscopic Injection of Mitomycin C for the Treatment of Pharyngoesophageal Stenosis | terminated | N/A | 12 | Fauze Maluf FilhoOTHER | 1 | May 30, 2018 | clinicaltrials |
| NCT01738633 | Quality of Life After Esophagectomy for Cancer - Step 2 | terminated | N/A | 80 | University of PadovaOTHER | 1 | May 23, 2018 | clinicaltrials |
| NCT02638909 | Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies | terminated | Phase 2 | 4 | Criterium, Inc.INDUSTRY | 1 | Apr 2, 2018 | clinicaltrials |
| NCT00827671 | Study of Combination of Cetuximab and Radiotherapy Added to the Standard Treatment for Oesophageal Adenocarcinoma(TRACC) | terminated | Phase 2 | 12 | P.O. WitteveenOTHER | 1 | Mar 9, 2018 | clinicaltrials |
| NCT01627379 | Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer(POWER) | terminated | Phase 3 | 300 | AIO-Studien-gGmbHOTHER | 1 | Mar 2, 2018 | clinicaltrials |
| NCT02392377 | Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy | terminated | Phase 2 | 1 | Case Comprehensive Cancer CenterOTHER | 1 | Feb 13, 2018 | clinicaltrials |
| NCT00256269 | Oxaliplatin and Irinotecan in Recurrent or Metastatic Esophageal and Gastroesophageal (GE) Junction Carcinoma | terminated | Phase 2 | 4 | University of California, IrvineOTHER | 1 | Jan 26, 2018 | clinicaltrials |
| NCT00848783 | Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers | terminated | Phase 2 | 8 | NYU Langone HealthOTHER | 1 | Jan 8, 2018 | clinicaltrials |
| NCT02157363 | POsitioning for Esophageal Cancer Resection(POETRI) | terminated | N/A | 47 | Technische Universität DresdenOTHER | 1 | Oct 20, 2017 | clinicaltrials |
| NCT01065818 | Early Prediction of Pathology Response of Chemoradiotherapy With FLT PET | terminated | N/A | 6 | Columbia UniversityOTHER | 1 | Sep 26, 2017 | clinicaltrials |
| NCT01740375 | Role of Esophagectomy in Complete Responders to CCRT(ESOPRESSO) | terminated | Phase 3 | 486 | Asan Medical CenterOTHER | 1 | Aug 29, 2017 | clinicaltrials |
| NCT00423150 | Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED) | terminated | Phase 2 | 86 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 8, 2017 | clinicaltrials |
| NCT00586404 | The Study of Barrett's Esophagus: What Are the Factors of Progression(BEST) | terminated | — | 1,250 | Midwest Biomedical ResearchOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT01572987 | Endoscopic Resection or Ablation for Patients With Dysplasia or Cancer Requiring Treatment of Barrett's Esophagus(ERADICATE) | terminated | N/A | 12 | Midwest Biomedical ResearchOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT01738620 | Quality of Life After Esophagectomy for Cancer - Step 1 | terminated | N/A | 74 | University of PadovaOTHER | 1 | Apr 12, 2017 | clinicaltrials |
| NCT01704690 | Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer | terminated | Phase 2 / Phase 3 | 4 | Peking UniversityOTHER | 1 | Apr 7, 2017 | clinicaltrials |
| NCT00190554 | A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell Carcinoma | terminated | Phase 3 | 330 | Japan Clinical Oncology GroupOTHER | 1 | Sep 22, 2016 | clinicaltrials |
| NCT00767234 | Permission to Collect Blood Over Time for Research | terminated | — | 104 | Stanford UniversityOTHER | 1 | Jul 11, 2016 | clinicaltrials |
| NCT00003381 | Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer [Companion to CALGB-9781] | terminated | — | 56 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT00268437 | Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery | terminated | Phase 2 | 27 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT00524186 | Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer | terminated | Phase 1 | 23 | Roswell Park Cancer InstituteOTHER | 1 | Jun 21, 2016 | clinicaltrials |
| NCT01870791 | Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric Cancer | terminated | Phase 2 | 21 | University Hospitals, LeicesterOTHER | 1 | May 26, 2016 | clinicaltrials |
| NCT02323776 | Defining the Radiotherapy Dose and Volume Parameters Affecting Postoperative Complications in Esophageal Cancer Patients | terminated | — | 150 | Maastricht Radiation OncologyOTHER | 1 | Mar 18, 2016 | clinicaltrials |
| NCT00130936 | Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates | terminated | Phase 1 / Phase 2 | 50 | AHS Cancer Control AlbertaOTHER | 1 | Feb 15, 2016 | clinicaltrials |
| NCT02283359 | Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus | terminated | Phase 1 | 3 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jan 15, 2016 | clinicaltrials |
| NCT00383266 | A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer | terminated | Phase 2 | 9 | Washington University School of MedicineOTHER | 1 | Jan 11, 2016 | clinicaltrials |
| NCT00109850 | S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer | terminated | Phase 2 | 22 | SWOG Cancer Research NetworkNETWORK | 1 | Nov 18, 2015 | clinicaltrials |
| NCT00093652 | Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer | terminated | Phase 1 / Phase 2 | — | Roswell Park Cancer InstituteOTHER | 1 | Oct 6, 2015 | clinicaltrials |
| NCT00442507 | Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction(OSI3650) | terminated | Phase 2 | 6 | Washington University School of MedicineOTHER | 1 | Jul 24, 2015 | clinicaltrials |
| NCT02023541 | Proton Beam Therapy to Treat Esophageal Cancer | terminated | Phase 1 | 3 | Washington University School of MedicineOTHER | 1 | Apr 7, 2015 | clinicaltrials |
| NCT00735345 | Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma | terminated | Phase 2 | 50 | Arbeitsgemeinschaft medikamentoese TumortherapieOTHER | 1 | Mar 9, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Oct 11, 2019source: clinicaltrials